Publications by authors named "Ulziibat Person"

Background: This study evaluated the impact of the mentorship model used in the psychiatry clerkship at Nassau University Medical Center (NUMC), with a focus on its effectiveness in improving medical knowledge and professional development in psychiatry.

Methods: This survey-based study at NUMC involved 16 attending psychiatrists and 13 past medical student mentees. Data were collected via electronic surveys from March to May 2022, examining effectiveness of mentorship and mentees' experiences.

View Article and Find Full Text PDF

Although data on the prevalence of anticholinergic misuse is scarce, it has been reported among psychiatric patients. Anticholinergic drugs can act as potent indirect dopamine agonists in the limbic system, a mechanism that has been hypothesized to explain their misuse potential among patients. In psychiatric practice settings, the use of typical antipsychotics in conjunction with anticholinergics is common, with the latter mainly used to manage extrapyramidal side effects of the former.

View Article and Find Full Text PDF

There are no medications that target the neurotoxic effects or reduce the use of methamphetamine. Recombinant T-cell receptor ligand (RTL) 1000 [a partial major histocompatibility complex (pMHC) class II construct with a tethered myelin peptide], addresses the neuroimmune effects of methamphetamine addiction by competitively inhibiting the disease-promoting activity of macrophage migration inhibitory factor to CD74, a key pathway involved in several chronic inflammatory conditions, including substance use disorders. We previously reported that RTL constructs improve learning and memory impairments and central nervous system (CNS) inflammation induced by methamphetamine in mouse models.

View Article and Find Full Text PDF